Peak Retirement Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.06M Buy
5,056
+990
+24% +$1.01M 0.96% 22
2026
Q1
$3.74M Buy
4,066
+3,423
+532% +$3.47M 0.75% 29
2025
Q4
$691K Buy
643
+86
+15% +$82.2K 0.16% 89
2025
Q3
$425K Buy
557
+9
+2% +$6.7K 0.12% 98
2025
Q2
$427K Buy
548
+143
+35% +$111K 0.17% 85
2025
Q1
$334K Buy
405
+117
+41% +$97.4K 0.19% 93
2024
Q4
$223K Buy
+288
New +$238K 0.15% 94

Other funds holding LLY

Peak Retirement Planning's LLY Position: Q2 2026 in Review

Peak Retirement Planning increased its Eli Lilly (LLY) stake by 24% in Q2 2026, buying an estimated $1.01M and bringing the position to 5,056 shares worth $6.06M. The position accounts for 0.96% of the portfolio, ranked #22.

Peak Retirement Planning first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,596 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Peak Retirement Planning held 5,056 shares of Eli Lilly worth $6.06M as of Q2 2026.
  • Peak Retirement Planning bought 990 Eli Lilly shares in Q2 2026, an estimated $1.01M.
  • Eli Lilly made up 0.96% of Peak Retirement Planning's portfolio in Q2 2026, its #22 holding.
  • Peak Retirement Planning first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,596 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Peak Retirement Planning's 13F filing for Q2 2026, filed 10 Aug 2026.